Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 477,102 shares of the medical equipment provider's stock after selling 3,100 shares during the period. New York State Common Retirement Fund owned 0.13% of Intuitive Surgical worth $249,028,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter valued at about $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 2.4 %

ISRG stock traded down $14.78 on Friday, hitting $591.79. The company's stock had a trading volume of 1,673,828 shares, compared to its average volume of 1,567,754. The firm has a 50 day moving average of $565.45 and a two-hundred day moving average of $525.06. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $210.78 billion, a price-to-earnings ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research report on Friday, January 24th. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective for the company. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Jefferies Financial Group raised their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $613.10.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company's stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.